References and Notes
1a
Schinazi RF.
Gosselin G.
Faraj A.
Korba BE.
Liotta DC.
Chu CK.
Mathe C.
Imbach J.-L.
Sommadossi J.-P.
Antimicrob. Agents Chemother.
1994,
38:
2172
1b
Okabe M.
Sun R.-C.
Tam SY.-K.
Todaro LJ.
Coffen DL.
J. Org. Chem.
1988,
53:
4780
1c
Spadari S.
Maga G.
Focher F.
Ciarrocchi G.
Manservigi R.
Arcamone F.
Capobianco M.
Carcuro A.
Colonna F.
Iotti S.
Garbesi A.
J. Med. Chem.
1992,
35:
4214
1d
Chu CK.
Ma TW.
Shanmuganathan K.
Wang G.
Xiang YJ.
Pai SB.
Yao GQ.
Sommadossi J.-P.
Cheng Y.-C.
Antimicrob. Agents Chemother.
1995,
39:
979
1e
Beach JW.
Jeong LS.
Alves AJ.
Pohl D.
Kim HO.
Chang C.-N.
Doong S.-L.
Schinazi RF.
Cheng Y.-C.
Chu CK.
J. Org. Chem.
1992,
57:
2217
1f
Kim HO.
Ahn SK.
Alves AJ.
Beach JW.
Jeong LS.
Choi BG.
Van Roey P.
Schinazi RF.
Chu CK.
J. Med. Chem.
1992,
35:
1987
1g
Lin TS.
Luo MZ.
Liu MC.
Pai SB.
Dutschman GE.
Cheng Y.-C.
J. Med. Chem.
1994,
37:
789
2a
Fujimori S.
Shudo K.
Hashimoto Y.
J. Am. Chem. Soc.
1990,
112:
7436
2b
Asseline U.
Hau J.-F.
Czernecki S.
Diguarher TL.
Perlat M.-C.
Valery J.-M.
Thuong NT.
Nucleic Acids Res.
1991,
19:
4067
2c
Damha MJ.
Giannaris PA.
Marfey P.
Reid LS.
Tetrahedron Lett.
1991,
32:
2573
3a
Uchimiya H.
Furukawa T.
Okamoto M.
Nakajima Y.
Matsushita S.
Ikeda R.
Gotanda T.
Haraguchi M.
Sumizawa T.
Ono M.
Kuwano M.
Kanzaki T.
Akiyama S.
Cancer Res.
2002,
62:
2834
3b
Nakajima Y.
Gotanda T.
Uchimiya H.
Furukawa T.
Haraguchi M.
Ikeda R.
Sumizawa T.
Yoshida H.
Akiyama S.
Cancer Res.
2004,
64:
1794
4a
Jung ME.
Nichols CJ.
Tetrahedron Lett.
1998,
39:
4615
4b
Jung ME.
Xu Y.
Org. Lett.
1999,
1:
1517
4c
Shi Z.-D.
Yang B.-H.
Wu Y.-L.
Tetrahedron
2002,
58:
3287
4d
Weymouth-Wilson AC.
Cowley AR.
Watkin DJ.
Fleet GWJ.
Tetrahedron: Asymmetry
2002,
13:
2667
4e
Fazio F.
Schneider MP.
Tetrahedron: Asymmetry
2000,
11:
1869
4f
Fazio F.
Schneider MP.
Tetrahedron: Asymmetry
2001,
12:
2143
4g
Hu S.-G.
Wu Y.-K.
Wu Y.-L.
Chinese J. Chem.
2002,
20:
1358
4h
Cho BH.
Kim JH.
Jeon HB.
Kim KS.
Tetrahedron
2005,
61:
4341
5
Sowden JC.
J. Am. Chem. Soc.
1954,
76:
3541
6
Deriaz RE.
Overend WG.
Stacey M.
Wiggins LF.
J. Chem. Soc.
1949,
2836
7
Crotti P.
Bussolo VD.
Favero L.
Macchia F.
Pineschi M.
Tetrahedron: Asymmetry
1996,
7:
779
8
Typical procedure for 2-deoxy-xylose: To a solution of 4 (10 g, 0.022 mol) in DMF (30 mL) was added potassium benzoate (30 g, 0.19 mol), and the mixture was heated at reflux with stirring for 10 h. The resulting mixture was concentrated and stirred with H2O (50 mL) and CH2Cl2 (30 mL), filtered, and the aqueous layer of the filtrate was separated and extracted with CH2Cl2 (30 mL). The combined organic layers were evaporated to dryness and the residue recrystallized from EtOH-H2O to give 7 as white crystals (3.9 g, 50%). This material was dissolved in MeOH (60 mL), the solution was saturated with NH3, and stirred at r.t. for 24 h. After evaporation, the residual syrup was partitioned between H2O (70 mL) and CH2Cl2 (70 mL), and the aqueous layer was separated and washed again with CH2Cl2 (50 mL). The resulting aqueous solution was saturated with benzoic acid and heated at reflux for 1 h. After cooling to r.t., CHCl3 (25 mL) was added, and the aqueous layer separated and washed again with CHCl3 (25 mL). The aqueous layer was concentrated to dryness and recrystallized from acetone-EtOAc (1:1) to give 2-deoxy-xylose (9) as white crystals (1.6 g, 83%). Single crystals suitable for X-ray diffraction measurements were obtained from acetone-EtOAc by slow evaporation at r.t. Analytical data: mp 77-78 °C; [α]20
D +0.6 (c 1.00, H2O); 1H NMR (300 MHz, DMSO-d
6): δ = 6.47 (d, J = 6.6 Hz, 1 H), 4.84 (dd, J
1 = 4.6 Hz, J
2 = 4.8 Hz, 2 H), 4.59-4.53 (m, 1 H), 3.68-3.62 (dd, J
1 = J
2 = 5.0 Hz, 1 H), 3.33-3.27 (m, 1 H), 3.19-3.10 (m, 1 H), 2.98-2.91 (m, 1H), 1.93-1.87 (dddd, J
1 = J
2 = J
3 = J
4 = 2.0 Hz, 1 H), 1.31-1.20 (m, 1 H); ESI-MS: m/z = 179 [M + HCOO-]; Anal. Calcd for C5H10O4: C, 44.77; H, 7.52. Found: C, 45.02; H, 7.33.
9a
Levene PA.
Mori T.
J. Biol. Chem.
1929,
83:
803
9b
Wong MYH.
Gray GR.
J. Am. Chem. Soc.
1978,
100:
3548
10 CCDC 293775 contains the supplementary crystallographic data and collection parameters for 9. These data can be obtained free of charge via ww.ccdc.cam.ac.uk/conts/retrieving.html.
11
Typical procedure for 2-deoxy-l-ribose: To a solution of 4 (10 g, 0.022 mol) in DMF (30 mL) was added H2O (5 mL) and potassium benzoate (25 g, 0.16 mol), and the mixture was heated at reflux with stirring for 6 h. The resulting mixture was concentrated and stirred with H2O (50 mL) and CH2Cl2 (30 mL), filtered, and the aqueous layer of the filtrate was separated and extracted with CH2Cl2 (30 mL). The organic layers were combined and treated with Na2CO3 and evaporated to a syrup (mixture 10). This material was dissolved in MeOH (60 mL), the solution saturated with NH3, and stirred at r.t. for 24 h. After evaporation, the residual syrup was partitioned between H2O (20 mL) and CH2Cl2 (20 mL), and the aqueous layer was separated and washed again with CH2Cl2 (20 mL) before being evaporated to dryness and the residue recrystallized from Et2O to give mixture 11 as a white solid (1.9 g, 46%). The solid was heated at reflux in a saturated aqueous solution of benzoic acid (80 mL) for 1 h. After cooling to r.t., CHCl3 (30 mL) was added, and the aqueous layer separated and washed again with CHCl3 (20 mL) before being concentrated to give a colorless syrup. The syrup was treated with a small amount of acetone-isopropanol (7:1) and refrigerated for about a week to give 2-deoxy-l-ribose (12) as a white powder (1.6 g, 95%). Data: mp 74-76 °C; [α]20
D +53 (c 1.00, H2O); 1H NMR (300 MHz, D2O): δ = 5.47-5.13 (m, 1 H), 4.22-3.42 (m, 4 H), 2.29-1.50 (m, 2 H); ESI-MS: m/z = 179 [M+HCOO-] (weak); Anal. Calcd for C5H10O4: C, 44.77; H, 7.52. Found: C, 44.61; H, 7.75.